top of page

Beware the 'Magic' Mushroom Gummy: The Hidden Dangers Lurking in Amanita Muscaria Products


WEDNESDAY, June 12, 2024 (HealthDay News) -- The rising trend of using “magic” psilocybin mushrooms for depression treatment has sparked an interest in another psychedelic mushroom, Amanita muscaria. However, a new study warns that this mushroom can be highly toxic and even deadly, making consumer awareness crucial.


Researchers at the University of California, San Diego, led by Eric Leas, have raised alarms about the dangers of Amanita muscaria. Unlike psilocybin, which is gaining recognition as an effective antidepressant, Amanita muscaria can be more toxic than fentanyl, cocaine, and PCP.


Many companies are marketing Amanita muscaria products, such as gummies and chocolates, as similar to psilocybin mushrooms. This practice is misleading and potentially dangerous. “Companies who are making these products are pushing the limits of our regulations. They are getting away with making a buck until someone tells them they can't,” said Leas in a university news release.


While both mushrooms have psychedelic effects, they work very differently in the body. Psilocybin activates serotonin receptors in the brain, promoting happiness and optimism. In contrast, Amanita muscaria suppresses the central nervous system, similar to alcohol and benzodiazepines, leading to effects like dizziness, muscle spasms, loss of coordination, agitation, seizures, coma, and even death.


Public interest in Amanita muscaria has surged, with Google searches increasing by 114% between 2022 and 2023. The mushroom’s compounds, muscimol and ibotenic acid, are being promoted as treatments for anxiety and depression.


However, the risks are severe. Last year, a 44-year-old man died after consuming four dried Amanita muscaria caps, and a 46-year-old woman was hospitalized after microdosing the mushroom for anxiety.


Given the severe health risks, researchers are calling for immediate regulatory actions. They suggest that federal authorities should classify Amanita muscaria as a controlled substance or at least restrict its use to adults and establish accurate dosing standards.


Consumers need to be aware of the hidden dangers of Amanita muscaria. Without proper regulation and clear distinctions between different types of psychedelic mushrooms, the risks remain high. The marketplace is currently a "buyer-beware" environment, making it crucial for consumers to stay informed and cautious.


Would You Take a Psychedelic Product Without Knowing Its Exact Ingredients?

  • Yes, if it's marketed as safe.

  • No, I want to know everything I'm ingesting.

  • Maybe, but only if recommended by a trusted source.



Comments


News (2).png
News (4).png
bottom of page